Advert - Sintetica

• Date posted
  12 March 2021
• Sanction
  Advertisement,
• Case number/s
  AUTH/3309/2/20 - Complainant v Sintetica

For promoting Ampres 20mg/ml solution for injection (chloroprocaine hydrochloride) to the public on a personal LinkedIn account, Sintetica was ruled in breach of the following clauses of the Code:

Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry

Clause 9.1 - Failing to maintain high standards

Clause 26.1 - Promoting a prescription only medicine to the public

Clause 26.2 - Encouraging members of the public to ask for a specific prescription only medicine.